Overview

Study of Pioglitazone in Sporadic Inclusion Body Myositis

Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
A study looking at the effect of pioglitazone in skeletal muscle of patients with sporadic inclusion body myositis (sIBM).
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Pioglitazone